Deletion of Wiskott–Aldrich syndrome protein triggers Rac2 activity and increased cross-presentation by dendritic cells
Wiskott–Aldrich syndrome (WAS) is a severe X-linked primary immunodeficiency syndrome. Here, the authors show that loss of WAS gene in dendritic cells results in increased activity of Rac2, increase of phagosomal pH, and more efficient cross-presentation.
Guardado en:
Autores principales: | Marisa A. P. Baptista, Marton Keszei, Mariana Oliveira, Karen K. S. Sunahara, John Andersson, Carin I. M. Dahlberg, Austen J. Worth, Agne Liedén, I-Chun Kuo, Robert P. A. Wallin, Scott B. Snapper, Liv Eidsmo, Annika Scheynius, Mikael C. I. Karlsson, Gerben Bouma, Siobhan O. Burns, Mattias N. E. Forsell, Adrian J. Thrasher, Susanne Nylén, Lisa S. Westerberg |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b30cb5531b534a4c9f3e0c5bebf69da8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Wiskott-Aldrich syndrome protein regulates autophagy and inflammasome activity in innate immune cells
por: Pamela P. Lee, et al.
Publicado: (2017) -
Wiskott Aldrich syndrome: healthcare utilizations and disparities in transplant care
por: Nikki Agarwal, et al.
Publicado: (2021) -
Targeted gene correction of human hematopoietic stem cells for the treatment of Wiskott - Aldrich Syndrome
por: Rajeev Rai, et al.
Publicado: (2020) -
Analysis of clinical and molecular genetic characteristics of Wiskott-Aldrich syndrome and X-linked thrombocytopenia
por: Doina TURCAN, et al.
Publicado: (2021) -
Trasplante alogénico de precursores hematopoyéticos en pacientes con síndrome de Wiskott-Aldrich
por: Wietstruck P,María Angélica, et al.
Publicado: (2007)